Search
Patexia Research
Case number 1:21-cv-01573

Boehringer Ingelheim Pharmaceuticals Inc. et al v. Sun Pharmaceutical Industries Limited et al > Documents

Date Field Doc. No.Description (Pages)
Jul 25, 2022 20 Notice Requesting Removal of Co-Counsel (1)
Docket Text: NOTICE requesting Clerk to remove Jason Z. Pesick as co-counsel. Reason for request: No Longer with Winston & Strawn LLP. (Bilson, David)
Apr 19, 2022 N/A Create Case Association (0)
Docket Text: Case associated with lead case: Create association to 1:21-cv-01485-CFC. ALL FUTURE FILINGS SHALL BE MADE IN LEAD CASE NO. 21-1485-CFC ONLY. (nmf)
Apr 18, 2022 N/A Oral Order (0)
Docket Text: ORAL ORDER: Civil Action Nos. 21-1485, 21-1486, 21-1487, 21-1573, 21-1766 and 22-220 are consolidated for all purposes. All future filings shall be made in Lead Case No. 21-1485-CFC only. Ordered by Judge Colm F. Connolly on 4/18/2022. Associated Cases: 1:21-cv-01485-CFC et al.(nmf)
Apr 13, 2022 N/A Status Conference (0)
Docket Text: Minute Entry for proceedings held before Judge Colm F. Connolly - In-Person Status Conference held on 4/13/2022. (Court Reporter Bonnie Archer.) Associated Cases: 1:18-cv-01689-CFC-SRF et al.(nmf)
Apr 7, 2022 19 Motion for Leave to Appear Pro Hac Vice (12)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Bryan S. Hales, Jeanna M. Wacker, Sam Kwon, and Ashley Ross - filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (Dellinger, Megan)
Apr 7, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (19 in 1:21-cv-01486-CFC, 29 in 1:21-cv-00530-CFC, 11 in 1:22-cv-00220-CFC, 21 in 1:21-cv-01766-CFC, 19 in 1:21-cv-01573-CFC, 19 in 1:21-cv-01485-CFC, 19 in 1:21-cv-01487-CFC) MOTION for Pro Hac Vice Appearance of Attorney Bryan S. Hales, Jeanna M. Wacker, Sam Kwon, and Ashley Ross, filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim International GmbH. Ordered by Judge Colm F. Connolly on 4/7/2022. Associated Cases: 1:21-cv-00530-CFC et al.(kmd)
Apr 5, 2022 N/A Oral Order (0)
Docket Text: ORAL ORDER Re-Setting Hearings, Due to a conflict in the Court's schedule, the In-Person Status Conference to discuss the parties' letters is rescheduled for 4/13/2022 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly.) Ordered by Judge Colm F. Connolly on 4/5/2022. Associated Cases: 1:21-cv-00530-CFC et al.(nmf)
Apr 1, 2022 18 Order (4)
Docket Text: ORDER, Setting Hearings: A Status Conference is set for 4/13/2022 at 11:00 AM in Courtroom 4B before Judge Colm F. Connolly to discuss the parties' letters. Signed by Judge Colm F. Connolly on 4/1/2022. Associated Cases: 1:21-cv-00530-CFC et al.(nmf)
Mar 17, 2022 N/A CORRECTING ENTRY: (0)
Docket Text: CORRECTING ENTRY: The pdf of the 3/15/2022 Letter to Honorable Colm F. Connolly from Megan E. Dellinger regarding response to Defendants March 11, 2022 letter has been replaced with a corrected version in order to to correct an error in the table on page 2 with respect to the answer date for defendant Laurus in the 22-220 action per request of filer. Associated Cases: 1:21-cv-00530-CFC et al.(nmf)
Mar 15, 2022 17 Letter (4)
Docket Text: Letter to Honorable Colm F. Connolly from Megan E. Dellinger regarding response to Defendants March 11, 2022 letter - re (25 in 1:21-cv-00530-CFC) Letter. (Dellinger, Megan) (Main Document 17 replaced on 3/17/2022) (nmf, ).
Mar 14, 2022 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Jason Z. Pesick for Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
Mar 11, 2022 16 Letter (4)
Docket Text: Letter to The Honorable Colm F. Connolly from John C. Phillips, Jr. regarding case management issues. (Phillips, John)
Mar 10, 2022 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Jovial Wong for Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)
Mar 10, 2022 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorney Charles B. Klein for Ohm Laboratories, Inc., Sun Pharmaceutical Industries Limited and Sun Pharmaceutical Industries, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:21-cv-01573-CFC, 1:21-cv-01487-CFC(mal)
Mar 9, 2022 15 Main Document (2)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Jovial Wong, Jason Z. Pesick and Sharon Lin - filed by Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc.. (Attachments: # (1) Certification of Charles B. Klein, # (2) Certification of Jovial Wong, # (3) Certification of Jason Z. Pesick, # (4) Certification of Sharon Lin)(Bilson, David)
Mar 9, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [15] MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein, Jovial Wong, Jason Z. Pesick and Sharon Lin, filed by Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries Limited, Ohm Laboratories, Inc. Ordered by Judge Colm F. Connolly on 3/9/2022. Associated Cases: 1:21-cv-01487-CFC, 1:21-cv-01573-CFC(kmd)
Mar 9, 2022 15 Certification of Charles B. Klein (1)
Mar 9, 2022 15 Certification of Jovial Wong (1)
Mar 9, 2022 15 Certification of Jason Z. Pesick (1)
Mar 9, 2022 15 Certification of Sharon Lin (1)
Mar 4, 2022 13 Answer to Complaint (30)
Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, COUNTERCLAIM against All Plaintiffs by Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc..(Phillips, John)
Mar 4, 2022 14 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sun Pharmaceuticals Industries Limited for Sun Pharmaceutical Industries, Inc. filed by Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc.. (Phillips, John)
Feb 8, 2022 12 Order (4)
Docket Text: ORDER: IT IS ORDERED that, on or before March 8, 2022, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted. ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 3/8/2022.) Signed by Judge Colm F. Connolly on 2/7/2022. Associated Cases: 1:21-cv-00530-CFC et al.(nmf)
Jan 19, 2022 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [11] Stipulation to Extend Time (Various Dates), filed by Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries Limited. Reset Answer Deadlines: Sun Pharmaceutical Industries Limited answer due 3/4/2022; Sun Pharmaceutical Industries, Inc. answer due 3/4/2022. Ordered by Judge Colm F. Connolly on 1/19/2022. (kmd)
Jan 18, 2022 11 Stipulation (2)
Docket Text: STIPULATION to Extend Time (Various Dates) - See Stipulation by Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc.. (Bilson, David)
Nov 30, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [10] STIPULATION TO EXTEND TIME, filed by Sun Pharmaceutical Industries, Inc., Sun Pharmaceutical Industries Limited. Reset Answer Deadlines: Sun Pharmaceutical Industries Limited answer due 1/18/2022; Sun Pharmaceutical Industries, Inc. answer due 1/18/2022. Ordered by Judge Colm F. Connolly on 11/30/2021. (kmd)
Nov 29, 2021 10 Stipulation to EXTEND Time (2)
Docket Text: STIPULATION TO EXTEND TIME Various to See Stipulation - filed by Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc.. (Bilson, David)
Nov 12, 2021 8 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Sun Pharmaceutical Industries, Inc. served on 11/11/2021, answer due 12/2/2021. (Dellinger, Megan)
Nov 12, 2021 9 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. Sun Pharmaceutical Industries Limited served on 11/11/2021, answer due 12/2/2021. (Dellinger, Megan)
Nov 10, 2021 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb)
Nov 4, 2021 1 Main Document (15)
Docket Text: COMPLAINT filed against Sun Pharmaceutical Industries Limited, Sun Pharmaceutical Industries, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3736886.) - filed by Boehringer Ingelheim Pharmaceuticals Inc., Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH. (Attachments: # (1) Exhibit 1-3, # (2) Civil Cover Sheet)(twk)
Nov 4, 2021 7 Summons Issued (2)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Sun Pharmaceutical Industries Limited on 11/5/2021. (twk)
Nov 4, 2021 6 Summons Issued (2)
Docket Text: Summons Issued with Magistrate Consent Notice attached as to Sun Pharmaceutical Industries, Inc. on 11/5/2021. (twk)
Nov 4, 2021 5 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent C. H. Boehringer Sohn AG & Co. KG for Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc. filed by Boehringer Ingelheim Corporation, Boehringer Ingelheim International GmbH, Boehringer Ingelheim Pharmaceuticals Inc.. (twk)
Nov 4, 2021 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,579,449 B2; 10,258,637 B2; 11,090,323 B2. (twk)
Nov 4, 2021 3 ANDA Form (1)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: September 24, 2021. Date of Expiration of Patent: U.S. Patent No. 7,579,449 expires on 8/1/2028; U.S. Patent Nos. 10,258,637 and 11,090,323 expire on 4/3/2034. Thirty Month Stay Deadline: March 24, 2024. (twk)
Nov 4, 2021 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk)
Nov 4, 2021 1 Civil Cover Sheet (1)
Nov 4, 2021 1 Exhibit 1-3 (139)
Nov 4, 2021 1 Complaint* (1)
Menu